Back to Search

GAIL ROBOZ, MD

MD

Hematology & Oncology Physician

NPI: 1417044504IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

200822(NY)
Hematology (Internal Medicine) Physician

Internal Medicine — Hematology

Code: 207RH0000X

200822(NY)
Medical Oncology Physician

Internal Medicine — Medical Oncology

Code: 207RX0202X

200822(NY)
Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

200822(NY)

CMS Specialties

PrimaryMEDICAL ONCOLOGY

Additional

HEMATOLOGY

Education

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Class of 1994

Research & Publications (20)

Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
PMID 18825661·Cancer·2008
3-trial
Arsenic and old lace: novel approaches in elderly patients with acute myeloid leukemia.
PMID 18760707·Semin Hematol·2008
6-review
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma.
PMID 17475326·Leuk Res·2007
5-case
Treatment of acute myeloid leukemia in older patients.
PMID 17338649·Expert Rev Anticancer Ther·2007
6-review
Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemia.
PMID 17146106·J Clin Oncol·2007
3-trial
Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome.
PMID 16617323·Leukemia·2006
3-trial
Efficacy and safety of gemtuzumab ozogamicin in patients with poor-prognosis acute myeloid leukemia.
PMID 12481890·Leuk Lymphoma·2002
3-trial
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis.
PMID 10942401·Blood·2000
8-other
Pomalidomide is active in the treatment of anemia associated with myelofibrosis.
PMID 19652059·J Clin Oncol·2009
3-trial
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial.
PMID 19557623·Leuk Lymphoma·2009
3-trial
Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.
PMID 19487385·J Clin Oncol·2009
3-trial
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.
PMID 19109557·Blood·2009
3-trial
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response.
PMID 19029442·Blood·2009
3-trial
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia.
PMID 18548095·Leukemia·2008
3-trial
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia.
PMID 17560285·Leuk Res·2007
3-trial
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.
PMID 17264298·Blood·2007
3-trial
Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia.
PMID 17146105·J Clin Oncol·2007
3-trial
Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma.
PMID 17020988·Clin Cancer Res·2006
3-trial
A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy.
PMID 16864057·Biol Blood Marrow Transplant·2006
3-trial
A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia.
PMID 16574225·Leuk Res·2006
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
520 E 70TH ST. STARR 341
NEW YORK, NY 10021

Location

Practice Location

520 E 70TH ST. STARR 341, NEW YORK, NY
(646) 962-2700

Quick Facts

NPI
1417044504
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
4
Locations
1
Years in Practice
32
Publications
20

Are you this provider?

Claim Your Profile